![]() | |
Names | |
---|---|
Preferred IUPAC name Cyclohexyl ([1,1′-biphenyl]-3-yl)carbamate | |
Other names [1,1′-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester | |
Identifiers | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider |
|
UNII | |
| |
| |
Properties | |
C19H21NO2 | |
Molar mass | 295.382 g·mol−1 |
Appearance | Crystalline solid |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
URB602 ([1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester) is a compound that has been found to inhibithydrolysis ofmonoacyl glycerol compounds, such as2-arachidonoylglycerol (2-AG) and2-oleoylglycerol (2-OG). It was first described in 2003.[1] A study performed in 2005 found that the compound had specificity for metabolizing 2-AG overanandamide (anothercannabinoid ligand) in rat brain presumably by inhibiting the enzymemonoacylglycerol lipase (MAGL), which is the primary metabolic enzyme of 2-AG.[2] However, subsequent studies have shown that URB602 lacks specificity for MAGL inhibitionin vitro.[3]
![]() | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |